|
|
||||||||
Department of Radiology and Nuclear Medicine, Research Institute for Cancer and Tuberculosis, and Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Clusterecore Institute of Biology, Sendai, Japan
Correspondence: For reprints contact: Roko Kubota, Department of Radiology and Nuclear Medicine, Research Institute for Cancer and Tbc., Tohoku University, 4-1 Seiryo-cho, Aoba-ku, Sendai 980, Japan.
ABSTRACT
While 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is a useful tumor imaging agent, its intratumoral distribution has not been described well at the cellular level. In order to demonstrate cellular localization of [18F]FDG and 2-deoxy-D-[3H]glucose (3H-DG) uptake by the tumor in vivo, C3H/He mice transplanted subcutaneously with FM3A tumors were studied 1 hr after intravenous injection of [18F]FDG or 3H-DG using micro- and macro-autoradiography. Fluorine-18-FDG and 3H-DG showed the same distribution pattern in the tumor with both autoradiographic methods. The newly formed granulation tissue around the tumor and macrophages, which were massively infiltrating the marginal areas surrounding necrotic area of the tumor showed a higher uptake of [18F]FDG than the viable tumor cells. A maximum of 29% of the glucose utilization was derived from nontumor tissue in this tumor. The comparison of double-tracer autoradiographic distribution patterns of [18F]FDG and [6-3H]-thymidine showed the differences and the similarities between glucose utilization and the DNA synthesis. Whole proliferating tissue metabolizes [18F]FDG but not vice versa. High accumulation of [18F]FDG in the tumor is believed to represent high metabolic activity of the viable tumor cells. Our results showed that one should consider not only the tumor cells proper but also the non-neoplastic cellular elements, which appear in association with growth or necrosis of the tumor cells, for precise analysis of [18F]FDG uptake in tumor-bearing subjects, especially after anti-neoplastic treatment.
This article has been cited by other articles:
![]() |
R. J. Hicks Time and Again, Children Resemble Their Parents J. Nucl. Med., October 1, 2008; 49(10): 1577 - 1578. [Full Text] [PDF] |
||||
![]() |
K. Herrmann, F. Eckel, S. Schmidt, K. Scheidhauer, B. J. Krause, J. Kleeff, T. Schuster, H.-J. Wester, H. Friess, R. M. Schmid, et al. In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors J. Nucl. Med., September 1, 2008; 49(9): 1437 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Forstner, J.-H. Egberts, O. Ammerpohl, D. Niedzielska, R. Buchert, P. Mikecz, U. Schumacher, K. Peldschus, G. Adam, C. Pilarsky, et al. Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer J. Nucl. Med., August 1, 2008; 49(8): 1362 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, M. Yamada, and Y. Suzuki 18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles J. Nucl. Med., July 1, 2008; 49(7): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kalliokoski, P. Nuutila, K. A. Virtanen, P. Iozzo, M. Bucci, E. Svedstrom, A. Roivainen, K. Nagren, T. Viljanen, H. Minn, et al. Pancreatic Glucose Uptake in Vivo in Men with Newly Diagnosed Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1909 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stadlbauer, O. Prante, C. Nimsky, E. Salomonowitz, M. Buchfelder, T. Kuwert, R. Linke, and O. Ganslandt Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging J. Nucl. Med., May 1, 2008; 49(5): 721 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Debnam, A.S. Garden, and L.E. Ginsberg Benign Ulceration as a Manifestation of Soft Tissue Radiation Necrosis: Imaging Findings AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 558 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, S. Basu, D. Torigian, V. Anand, H. Zhuang, and A. Alavi Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography Clin. Microbiol. Rev., January 1, 2008; 21(1): 209 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhao, Y. Kuge, M. Kohanawa, T. Takahashi, Y. Zhao, M. Yi, K. Kanegae, K.-i. Seki, and N. Tamaki Usefulness of 11C-Methionine for Differentiating Tumors from Granulomas in Experimental Rat Models: A Comparison with 18F-FDG and 18F-FLT J. Nucl. Med., January 1, 2008; 49(1): 135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Sung, K. S. Lee, B.-T. Kim, S. Kim, O J. Kwon, J. Y. Choi, and S.-O. Yang Nonpalpable Supraclavicular Lymph Nodes in Lung Cancer Patients: Preoperative Characterization with 18F-FDG PET/CT Am. J. Roentgenol., January 1, 2008; 190(1): 246 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Metser, E. Miller, H. Lerman, and E. Even-Sapir Benign Nonphysiologic Lesions with Increased 18F-FDG Uptake on PET/CT: Characterization and Incidence Am. J. Roentgenol., November 1, 2007; 189(5): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamamoto, T. Z. Wong, T. G. Turkington, T. C. Hawk, and R. E. Coleman Head and Neck Cancer: Dedicated FDG PET/CT Protocol for Detection--Phantom and Initial Clinical Studies Radiology, July 1, 2007; 244(1): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tan, D. J. Adelstein, L. A. Rybicki, J. P. Saxton, R. M. Esclamado, B. G. Wood, R. R. Lorenz, M. Strome, and M. A. Carroll Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy Arch Otolaryngol Head Neck Surg, May 1, 2007; 133(5): 435 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brepoels, S. Stroobants, P. Vandenberghe, K. Spaepen, P. Dupont, J. Nuyts, G. Bormans, L. Mortelmans, G. Verhoef, and C. De Wolf-Peeters Effect of Corticosteroids on 18F-FDG Uptake in Tumor Lesions After Chemotherapy J. Nucl. Med., March 1, 2007; 48(3): 390 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Meller, C.-O. Sahlmann, and A. K. Scheel 18F-FDG PET and PET/CT in Fever of Unknown Origin J. Nucl. Med., January 1, 2007; 48(1): 35 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igai, M. Gotoh, and H. Yokomise Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 837 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tahara, H. Kai, M. Ishibashi, H. Nakaura, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi Simvastatin Attenuates Plaque Inflammation: Evaluation by Fluorodeoxyglucose Positron Emission Tomography J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1825 - 1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, H. Takinami, Y. Iwado, K. Satoh, and M. Ohkawa Comparative Evaluation of 18F-FDG PET and 67Ga Scintigraphy in Patients with Sarcoidosis J. Nucl. Med., October 1, 2006; 47(10): 1571 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadithi, M. Mallant, J. Oudejans, J.-H. T.M. van Waesberghe, C. J. Mulder, and E. F.I. Comans 18F-FDG PET Versus CT for the Detection of Enteropathy-Associated T-Cell Lymphoma in Refractory Celiac Disease J. Nucl. Med., October 1, 2006; 47(10): 1622 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Cascini, A. Avallone, P. Delrio, C. Guida, F. Tatangelo, P. Marone, L. Aloj, F. De Martinis, P. Comella, V. Parisi, et al. 18F-FDG PET Is an Early Predictor of Pathologic Tumor Response to Preoperative Radiochemotherapy in Locally Advanced Rectal Cancer J. Nucl. Med., August 1, 2006; 47(8): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Apisarnthanarax, M. M. Alauddin, F. Mourtada, H. Ariga, U. Raju, O. Mawlawi, D. Han, W. G. Bornmann, J. A. Ajani, L. Milas, et al. Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3'-Deoxy-3'-3H-Fluorothymidine Using Preclinical Tumor Models Clin. Cancer Res., August 1, 2006; 12(15): 4590 - 4597. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Vandecaveye, F de Keyzer, V Vander Poorten, K Deraedt, H Alaerts, W Landuyt, S Nuyts, and R Hermans Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases Br. J. Radiol., August 1, 2006; 79(944): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dumarey, D. Egrise, D. Blocklet, B. Stallenberg, M. Remmelink, V. del Marmol, G. Van Simaeys, F. Jacobs, and S. Goldman Imaging Infection with 18F-FDG-Labeled Leukocyte PET/CT: Initial Experience in 21 Patients J. Nucl. Med., April 1, 2006; 47(4): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, N. Kimura, A. Miki, Y. Sasakawa, H. Wakabayashi, K. Satoh, and M. Ohkawa Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma J. Nucl. Med., April 1, 2006; 47(4): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pauleit, A. Zimmermann, G. Stoffels, D. Bauer, J. Risse, M. O. Fluss, K. Hamacher, H. H. Coenen, and K.-J. Langen 18F-FET PET Compared with 18F-FDG PET and CT in Patients with Head and Neck Cancer J. Nucl. Med., February 1, 2006; 47(2): 256 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van Waarde, P. L. Jager, K. Ishiwata, R. A. Dierckx, and P. H. Elsinga Comparison of Sigma-Ligands and Metabolic PET Tracers for Differentiating Tumor from Inflammation J. Nucl. Med., January 1, 2006; 47(1): 150 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bleeker-Rovers, F. J. Vos, G. J.A. Wanten, J. W.M. van der Meer, F. H.M. Corstens, B.-J. Kullberg, and W. J.G. Oyen 18F-FDG PET in Detecting Metastatic Infectious Disease J. Nucl. Med., December 1, 2005; 46(12): 2014 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Shu, S. Guo, Y. J. Kim, S. M. Shelly, A. Nijagal, P. Ray, S. S. Gambhir, C. G. Radu, and O. N. Witte Visualization of a primary anti-tumor immune response by positron emission tomography PNAS, November 29, 2005; 102(48): 17412 - 17417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Abouzied, E. S. Crawford, and H. A. Nabi 18F-FDG Imaging: Pitfalls and Artifacts J. Nucl. Med. Technol., September 1, 2005; 33(3): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Love, M. B. Tomas, G. G. Tronco, and C. J. Palestro FDG PET of Infection and Inflammation RadioGraphics, September 1, 2005; 25(5): 1357 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Movahed Failure of Gated Single Photon Emission Computer Tomography Scan to Detect Imminent Acute Plaque Rupture Causing Acute ST-Elevation Myocardial Infarction: Case Report Chest, August 1, 2005; 128(2): 1043 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishimaru, I. Tsujino, T. Takei, E. Tsukamoto, S. Sakaue, M. Kamigaki, N. Ito, H. Ohira, D. Ikeda, N. Tamaki, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur. Heart J., August 1, 2005; 26(15): 1538 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Fukui, T. M. Blodgett, C. H. Snyderman, J. J. Johnson, E. N. Myers, D. W. Townsend, and C. C. Meltzer Combined PET-CT in the Head and Neck: Part 2. Diagnostic Uses and Pitfalls of Oncologic Imaging RadioGraphics, July 1, 2005; 25(4): 913 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wells, R. N. Gunn, C. Steel, A. S. Ranicar, F. Brady, S. Osman, T. Jones, and P. Price 2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans Clin. Cancer Res., June 15, 2005; 11(12): 4341 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Weber Use of PET for Monitoring Cancer Therapy and for Predicting Outcome J. Nucl. Med., June 1, 2005; 46(6): 983 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leyton, J. R. Latigo, M. Perumal, H. Dhaliwal, Q. He, and E. O. Aboagye Early Detection of Tumor Response to Chemotherapy by 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivo Cancer Res., May 15, 2005; 65(10): 4202 - 4210. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtsuka, H. Nomori, K. Watanabe, T. Naruke, H. Orikasa, K. Yamazaki, K. Suemasu, and K. Uno False-positive Findings on [18F]FDG-PET Caused by Non-neoplastic Cellular Elements After Neoadjuvant Chemoradiotherapy for Non-small Cell Lung Cancer Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 271 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhao, Y. Kuge, T. Mochizuki, T. Takahashi, K. Nakada, M. Sato, T. Takei, and N. Tamaki Biologic Correlates of Intratumoral Heterogeneity in 18F-FDG Distribution with Regional Expression of Glucose Transporters and Hexokinase-II in Experimental Tumor J. Nucl. Med., April 1, 2005; 46(4): 675 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. van Westreenen, D. C.P. Cobben, P. L. Jager, H. M. van Dullemen, J. Wesseling, P. H. Elsinga, and J. Th. Plukker Comparison of 18F-FLT PET and 18F-FDG PET in Esophageal Cancer J. Nucl. Med., March 1, 2005; 46(3): 400 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kersemans, B. Cornelissen, K. Kersemans, M. Bauwens, E. Achten, R. A. Dierckx, J. Mertens, and G. Slegers In Vivo Characterization of 123/125I-2-Iodo-L-Phenylalanine in an R1M Rhabdomyosarcoma Athymic Mouse Model as a Potential Tumor Tracer for SPECT J. Nucl. Med., March 1, 2005; 46(3): 532 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, T. J. Mangner, J. M. Collins, O. Muzik, K. Douglas, and A. F. Shields Imaging DNA Synthesis In Vivo with 18F-FMAU and PET J. Nucl. Med., February 1, 2005; 46(2): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hooft, A. A. M. van der Veldt, P. J. van Diest, O. S. Hoekstra, J. Berkhof, G. J. J. Teule, and C. F. M. Molthoff [18F]Fluorodeoxyglucose Uptake in Recurrent Thyroid Cancer Is Related to Hexokinase I Expression in the Primary Tumor J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 328 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kazama, S. C. Faria, V. Varavithya, S. Phongkitkarun, H. Ito, and H. A. Macapinlac FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls RadioGraphics, January 1, 2005; 25(1): 191 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.P. Cobben, P. H. Elsinga, H. J. Hoekstra, A. J.H. Suurmeijer, W. Vaalburg, B. Maas, P. L. Jager, and H. M.J. Groen Is 18F-3'-Fluoro-3'-Deoxy-L-Thymidine Useful for the Staging and Restaging of Non-Small Cell Lung Cancer? J. Nucl. Med., October 1, 2004; 45(10): 1677 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugiyama, H. Sakahara, K. Sato, N. Harada, D. Fukumoto, T. Kakiuchi, T. Hirano, E. Kohno, and H. Tsukada Evaluation of 3'-Deoxy-3'-18F-Fluorothymidine for Monitoring Tumor Response to Radiotherapy and Photodynamic Therapy in Mice J. Nucl. Med., October 1, 2004; 45(10): 1754 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Buck, G. Glatting, and S. N. Reske Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker? J. Nucl. Med., August 1, 2004; 45(8): 1274 - 1276. [Full Text] [PDF] |
||||
![]() |
J. K. Koort, T. J. Makinen, J. Knuuti, J. Jalava, and H. T. Aro Comparative 18F-FDG PET of Experimental Staphylococcus aureus Osteomyelitis and Normal Bone Healing J. Nucl. Med., August 1, 2004; 45(8): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Strauss, M. Dunphy, and N. Tokita Imaging the Vulnerable Plaque: A Scintillating Light at the End of the Tunnel? J. Nucl. Med., July 1, 2004; 45(7): 1106 - 1107. [Full Text] [PDF] |
||||
![]() |
J.-H. Chung, K.-J. Cho, S.-S. Lee, H. J. Baek, J.-H. Park, G. J. Cheon, C.-W. Choi, and S. M. Lim Overexpression of Glut1 in Lymphoid Follicles Correlates with False-Positive 18F-FDG PET Results in Lung Cancer Staging J. Nucl. Med., June 1, 2004; 45(6): 999 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Min, S. Biswal, C. Deroose, and S. S. Gambhir Tetraphenylphosphonium as a Novel Molecular Probe for Imaging Tumors J. Nucl. Med., April 1, 2004; 45(4): 636 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van Waarde, D. C.P. Cobben, A. J.H. Suurmeijer, B. Maas, W. Vaalburg, E. F.J. de Vries, P. L. Jager, H. J. Hoekstra, and P. H. Elsinga Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model J. Nucl. Med., April 1, 2004; 45(4): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1087 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maschauer, O. Prante, M. Hoffmann, J. T. Deichen, and T. Kuwert Characterization of 18F-FDG Uptake in Human Endothelial Cells In Vitro J. Nucl. Med., March 1, 2004; 45(3): 455 - 460. [Abstract] [Full Text] |
||||
![]() |
A. K. Buck and S. N. Reske Cellular Origin and Molecular Mechanisms of 18F-FDG Uptake: Is There a Contribution of the Endothelium? J. Nucl. Med., March 1, 2004; 45(3): 461 - 463. [Full Text] |
||||
![]() |
H. A. Wieder, B. L.D.M. Brucher, F. Zimmermann, K. Becker, F. Lordick, A. Beer, M. Schwaiger, U. Fink, J. R. Siewert, H. J. Stein, et al. Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment J. Clin. Oncol., March 1, 2004; 22(5): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Antoch, G. M. Kaiser, A. B. Mueller, K. A. Metz, H. Zhang, H. Kuehl, S. Westermann, C. E. Broelsch, S. P. Mueller, A. Bockisch, et al. Intraoperative Radiation Therapy in Liver Tissue in a Pig Model: Monitoring with Dual-Modality PET/CT Radiology, March 1, 2004; 230(3): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lim, C. Wittram, J. A. Ferry, and J.-A. O. Shepard FDG PET of Rosai-Dorfman Disease of the Thymus Am. J. Roentgenol., February 1, 2004; 182(2): 514 - 514. [Full Text] [PDF] |
||||
![]() |
J. E.M. van Eerd, P. Laverman, W. J.G. Oyen, T. D. Harris, D. S. Edwards, C. E. Ellars, F. H.M. Corstens, and O. C. Boerman Imaging of Experimental Colitis with a Radiolabeled Leukotriene B4 Antagonist J. Nucl. Med., January 1, 2004; 45(1): 89 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Paik, K.-H. Lee, Y. S. Choe, Y. Choi, and B.-T. Kim Augmented 18F-FDG Uptake in Activated Monocytes Occurs During the Priming Process and Involves Tyrosine Kinases and Protein Kinase C J. Nucl. Med., January 1, 2004; 45(1): 124 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.P. Cobben, P. L. Jager, P. H. Elsinga, B. Maas, A. J.H. Suurmeijer, and H. J. Hoekstra 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma? J. Nucl. Med., December 1, 2003; 44(12): 1927 - 1932. [Abstract] [Full Text] [PDF] |